Related Experiment Video
Updated: Sep 28, 2025
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
A Treatable Genetic Disease Caused by CAD Mutation
Xia Peng1, Li-Ping Xia1, Hai-Ju Zhang1
1Department of Pediatrics, Renmin Hospital of Wuhan University, Wuhan, China.
Insights
Early infantile epileptic encephalopathy type 50 (EIEE-50) is a rare genetic disorder caused by CAD mutations. Uridine treatment showed promising results in a patient with EIEE-50, improving developmental delay and epilepsy.
Area of Science:
- Genetics
- Neurology
- Pediatrics
Background:
- Early infantile epileptic encephalopathy type 50 (EIEE-50) is a rare autosomal recessive disorder.
- It is caused by mutations in the CAD gene, with limited existing literature.
- Affected individuals often present with severe neurological and developmental challenges.
Purpose of the Study:
- To report a case of EIEE-50 in a young male patient.
- To highlight the diagnostic findings, including compound heterozygous CAD mutations.
- To evaluate the efficacy of uridine treatment for EIEE-50.
Main Methods:
- Whole-exome sequencing was performed to identify genetic mutations.
- Clinical data including developmental status, epilepsy, and anemia were recorded.
- The patient received uridine treatment, and outcomes were monitored.
Main Results:
- The patient was diagnosed with EIEE-50 due to compound heterozygous CAD mutations.
- He exhibited global developmental delay, regression, refractory epilepsy, and anemia.
- Uridine treatment led to encouraging clinical improvements.
Conclusions:
- This case expands the understanding of EIEE-50 clinical presentation and genetic basis.
- Uridine therapy presents a potential therapeutic option for EIEE-50.
- Further research is warranted to confirm uridine's efficacy and optimize treatment strategies.
Abstract:
Type 50 early infantile epileptic encephalopathy, or EIEE-50 for short, is an autosomal recessive genetic disorder resulting from CAD mutations. So far, little has been reported on the disease. In this article, we will discuss the case of a male infant who is 8 years and 5 months old. A whole-exome sequencing of the boy revealed CAD compound heterozygous mutations. He suffered from global developmental delay and regression, refractory epilepsy, and anemia. After his diagnosis, we used uridine treatment and gained encouraging results. In this article, we will analyze our case studies in the context of the literature, so as to improve pediatricians' understanding of the disease.
More Related Videos
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
01:39Mutations
01:11Genetic Lingo
01:31Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
01:43Incomplete Dominance
01:19Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...